Sagimet Biosciences Inc (SGMT) PT Raised to $33 at Oppenheimer

April 30, 2026 5:26 PM

Oppenheimer analyst Jay Olson raised the price target on Sagimet Biosciences Inc (NASDAQ: SGMT) to $33.00 (from $28.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found